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Background: Previous studies of the relationship between the menstrual phases and smoking behavior have been
problematic, so the association of menstrual phases with smoking behavior and correlations among smoking,
psychological and physical conditions in each phase of the menstrual cycle are unclear.
Methods: To accurately examine the association between menstrual phases and the amount of smoking (number
of cigarettes smoked and breath CO concentration), craving of smoking on visual analogue scale (VAS), depression
in the Center for Epidemiologic Studies Depression (CES-D) Scale, and menstrual phase-associated symptoms in the
Menstrual Distress Questionnaire (MDQ), we improved various methodological issues, specifically, 1) Ovulation was
confirmed by measuring the basal body temperature and identifying a urinary luteinizing hormone (LH) surge in
two cycles; 2) The menstrual, follicular, and luteal phases were clearly defined for subjects with different menstrual
cycles; 3) The breath CO concentration was measured every day. A notice was posted on public bulletin boards to
recruit research subjects and twenty-nine young Japanese women smokers aged 19 to 25 years old were analyzed.
Results: The number of cigarettes smoked was greater and the CO concentration was higher in the luteal phase
than in the follicular phase. The levels of craving for smoking (VAS), depressiveness (CES-D), and menstrual phase-
associated symptoms (MDQ) in the menstrual and luteal phases were higher than those in the follicular phase.
The mean score for CES-D was 16 points (the cut-off value in screening for depression) or higher in the menstrual
(16.9 ± 8.2) and luteal phases (17.2 ± 8.4).
The number of cigarettes smoked and CO concentration were significantly correlated with the levels of craving for
smoking, depressiveness, and menstrual phase-associated symptoms in all phases except for MDQ scores in
follicular phase. The amount of smoking in the luteal phase was most strongly correlated with these symptoms.
Conclusions: In the menstrual and luteal phases, young Japanese women smokers increased their amount of
smoking and suffered from greater craving for smoking, depressiveness and menstrual phase-associated symptoms.
The amount of smoking was correlated with these symptoms, but their cause-effect relationship has not been
determined yet.
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Females of reproductive age develop a variety of physical
and psychological symptoms in the menstrual and luteal
phases, which may require medical intervention in ser-
ious cases [1]. It has been considered that women smo-
king behavior fluctuates across the menstrual cycle and
that women may smoke to alleviate symptoms associated
with the menstrual cycle. Since the 1980s, a large num-
ber of studies have been conducted on the relationship
between the menstrual cycle and changes in the amount
of smoking. The studies [2-4], excluding one [5], pub-
lished in the first half of the 1990s or earlier reported an
increase in the amount of smoking in the luteal phase.
However, in most of these studies, the basal body
temperature or hormone level in the blood was not mea-
sured to accurately define each phase of the menstrual
cycle. Several studies conducted in the 1990s tried to
define the phases by measuring blood hormone levels
and detecting a urinary luteinizing hormone (LH) surge
to confirm ovulation [6-10]. Furthermore, although these
studies measured concentrations of breath carbon mon-
oxide (CO) and urinary cotinine, a metabolite of nico-
tine, to objectively assess the amount of smoking, they
did not provide consistent results regarding the relation-
ship between the amount of smoking and the menstrual
cycle. According to a study conducted by DeBon et al.
[8], there was an increase in the number of cigarettes
smoked in the menstrual and luteal phases compared to
the ovulatory phase, although no changes were noted in
breath CO and urinary cotinine levels. In contrast, Allen
et al. [6,7], reported no marked changes in the number
of cigarettes smoked and breath CO and urinary cotin-
ine levels between each phase of the menstrual cycle.
Our previous study [11] reported that young Japanese
women smokers had more severe menstrual phase-
associated (menstrual and premenstrual) symptoms than
non-smokers and that the severity of menstrual phase-
associated symptoms was markedly correlated with nico-
tine dependency and motivation for smoking.
It has been pointed out that previous studies of the
relationship between the menstrual cycle and smoking
involved a variety of problems. In their review of the
relationship between smoking and the menstrual cycle,
Carpenter et al. [12] suggested that in most of the previ-
ous studies confirmation of ovulation was insufficient,
the follicular and luteal periods were not clearly defined,
and objective indices (blood and urinary cotinine con-
centrations and breath CO concentration) were not used
to assess the daily amount of smoking. Secondly, pa-
tients with depression, dysmenorrhea, and premenstrual
syndrome were not excluded from research subjects,
which presumably affected the research results. Further-
more, as the subjects of previous studies were women
in their 20s to 40s, there might have been age-relateddifferences in symptoms associated with the menstrual
cycle and smoking status.
By addressing the problems described above, the present
study involving young Japanese women examined the
changes of the amount of smoking among menstrual
phases and the relationships between the amount of
smoking versus the levels of craving for smoking, de-
pressiveness, and menstrual phase-associated symptoms
in the menstrual, follicular, and luteal phases.
Methods
Participants
The study was conducted between August 1, 2009 and
April 15, 2010. A notice was posted on seven bulletin
boards in the Osaka City Health Center and Aino
University to recruit research subjects from among women
smokers in their twenties. The researcher provided each
applicant with verbal and written explanations of the
purpose of the study and the method for the completion of
a study form in a private room, and obtained written
consent.
The subjects were 33 women who provided written
consent. An electronic thermometer and instrument for
measuring breath CO concentrations were lent to the
subjects. Question items included age, occupation, the
number of cigarettes smoked each day, and days of men-
strual cycle and days of menses during the past three
months. The level of nicotine dependence was deter-
mined by the Fagerström Test for Nicotine Dependency
(FTND) [13]. The FTND consists of 6 items and its
score is calculated as the total sum of scores. The total
score ranges from 0 to 10 and a higher score indicates
higher nicotine dependency. Scores 0 to 3 indicate mild
dependency, scores 4 to 6 indicate moderate depen-
dency, and scores 7 to 10 indicate severe dependency.
For this questionnaire examination, subjects were re-
quired to satisfy the following conditions: 1) The men-
strual cycle was 25 to 38 days and duration of menses was
3 to 7 days for at least over the past year; Those who: 2)
have not been diagnosed with dysmenorrhea or premens-
trual syndrome; 3) have no history of gynecological
diseases and do not regularly use drugs for menstrual
symptoms; 4) do not use hormonal contraceptive pills or
receive drug treatment for chronic diseases; 5) are not
pregnant or in the lactation period; 6) have no history of
mental disorders; 7) have been smoking at least ten
cigarettes a day for at least the past year; 8) are in their
twenties and have not married or given birth.
After obtaining consent from the subjects, a preliminary
study (measurement for one menstrual cycle) was con-
ducted. In the preliminary study, the same procedures as
those in the main study were implemented to help the
subjects learn the required techniques. As a result of the
preliminary study, two women were diagnosed as having
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ger, and one as probably having premenstrual syndrome.
As a woman also withdrew from the study at this point,
29 subjects participated in the main study.
Procedure
Definition of each phase of the menstrual cycle
Each phase of the menstrual cycle was determined during
two menstrual cycles of the study period. The present
study defined the period between the start and end of
menstruation as the menstrual phase, the three-day period
including the day in which an LH surge was identified plus
the previous and following days as the ovulatory phase,
the period between the menstrual and ovulatory phases as
the follicular phase, and the period between the ovulatory
and menstrual phases as the luteal phase.
Confirmation of ovulation
The subjects were asked to measure their basal body
temperature (BBT) in every morning, and undergo a
urinary LH test between the day after the end of men-
struation and confirmation of an LH surge. The subjects
recorded their results on a calendar every day.
Craving for smoking, depressiveness and menstrual phase-
associated symptoms
Using the 100-mm Visual Analogue Scale (VAS), the
subjects recorded their level of craving for smoking as a
score from 0 [I do not feel like smoking] to 100 [I cannot
help but smoke] every morning at the same time as BBT
measurements.
A questionnaire survey was conducted to examine the
level of depressiveness and menstrual phase-associated
symptoms in the menstrual, follicular, and luteal phases.
Each subject received the questionnaire form after
consenting to the study, and sent it to us by mail after
completing it. Dates for recording data in the form were
determined based on the results of measurement of BBT
and date of ovulation determined by a urinary LH surge.
Symptoms in the menstrual phase were recorded within
three days of the start of menstruation, and those in the
follicular phase were recorded 3 to 5 days after the end
of menstruation. Symptoms in the luteal phase were
recorded between 10 days after confirming an LH surge
and the start of the next menstruation.
The level of depressiveness was assessed using the
Center for Epidemiologic Studies Depression (CES-D)
Scale [14]. The CES-D is a four-grade (0 to 3 scores)
scale for the self-assessment of depression, and includes
20 question items. The Japanese version of the CES-D
was used in this study [15]. The total score is between 0
and 60. A subject with a total score of 16 or higher is
determined as having depressiveness.Symptoms associated with the menstrual cycle were
assessed using the Menstrual Distress Questionnaire
(MDQ) [16]. The MDQ is a four-grade (none - severe)
scale and includes 47 symptoms and 8 sub-categories
(the first: pain, second: impaired concentration, third:
behavior change, fourth: autonomic reactions, fifth:
water retention, sixth: negative affect, seventh: arousal,
eighth: control). The reliability of the Japanese version of
the MDQ used in the study has been established [17].
Tobacco consumption
To assess the amount of smoking, the subjects measured
their breath CO concentration before bedtime every day
and recorded it on a calendar along with the number of
cigarettes smoked that day. Breath CO levels were mea-
sured using a MicroSmokerlyzer (Bedfont Scientific Ltd.
UK) [detection range: 0 to 500 ppm; accuracy: ± 10%].
Other study items
The days on which the subjects drank alcohol were
marked on a calendar during the study. The days the sub-
jects had no chance to smoke were also marked in the
same manner. Data from these days were excluded from
the analysis.
Ethical considerations
The present study was conducted with the approval of
the research ethics committees of Osaka University
Graduate School of Medicine and Aino University. The
anonymity of the subjects was preserved. The subjects
are allowed to quit smoking if they so wished during the
research period, and could receive treatment for nicotine
addiction or symptoms associated with the menstrual
phase. The subjects received book tokens worth 2,000
Japanese yen as remuneration.
Analysis methods
Using the descriptive statistics method, the attributes of
research subjects, smoking status, and data on menstrual
cycles were analyzed.
The number of cigarettes smoked and CO concen-
tration during two menstrual cycles in the menstrual,
follicular, and luteal phases were compared. The number
of cigarettes smoked and CO concentration were ana-
lyzed using one-way repeated measures analysis of vari-
ance (ANOVA) and Tukey’s multiple comparison test.
The levels of craving for smoking, depression, and men-
strual phase-associated symptoms during two menstrual
cycles were compared among the menstrual, follicular,
and luteal phases. Scores for each item were analyzed
using one-way repeated measures ANOVA and Tukey’s
multiple comparison test.
Pearson’s correlation coefficient was calculated between
the amount of smoking (number of cigarettes smoked and
Table 1 Characteristics of subjects
Mean (SD) Range
Age (years) 21.1 (1.7) 197–25
Daily number of cigarettes smoked 17.3 (5.2) 10.5–30.0
Years of smoking 3.6 (2.1) 1–10
FTND score 2.2 (2.1) 0–7
Duration of menstrual cycle (days) 30.5 (2.5) 37–34
Duration of follicular phase (days) 8.2 (2.1) 6–9
Duration of luteal phase (days) 12.6 (1.4) 12–15
FTND: Fagerström Test for Nicotine Dependency.
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depression, and menstrual phase-associated symptoms.
Statistical analysis software SPSS17.0 J for Windows was
used for analyses. The significance level was set at p = 0.05
and p-values were based on 2-sided test.
Results
Subjects were 15 full-time employees, 3 part-timers, and
11 students. Their age, smoking status and condition of
menstruation are shown in Table 1.
The number of cigarettes smoked and the CO concen-
tration were significantly different among the menstrual
phases (F(2,84) = 3.178, p = 0.007, partial eta-squared =
0.081; F(2,84) = 3.161, p = 0.019, partial eta-squared =
0.070, respectively) (Table 2). The number of cigarettes
was greater (p = 0.028) and the CO concentration was
higher (p = 0.034) in the luteal phase than in the follicular
phase. A marked relationship was noted between the
number of cigarettes smoked and CO concentration
in the menstrual(r = 0.735,p < 0.001), follicular(r = 0.765,
p < 0.001) and luteal phases(r = 0.810,p < 0.001).
The levels of craving for smoking (VAS), depressiveness
(CES-D) and menstrual phase-associated symptoms
(MDQ) were significantly different among three phases
(F(2,84) = 13.681, p < 0.001, partial eta-squared = 0.246;
F(2,84) = 5.154, p < 0.001, partial eta-squared = 0.109;
F(2,84) = 17.532, p < 0.001, partial eta-squared = 0.249,
respectively). These symptoms in the menstrual and
luteal phases were significantly higher than those in
the follicular phase (Figure 1). In particular, the mean
score for depressiveness was 16 points (the cut-off valueTable 2 Amount of smoking (number of cigarettes smoked an
luteal phases
Menstrual mean (SD) Follicul
Number of cigarettes (per day) 16.1 (5.6) 14
Range 10.0–30.0 10
CO concentration (ppm) 15.5 (5.8) 14
Range 3.7-28.0 4
1) p = 0.028, 2) p = 0.034.
Data were analyzed by one-way repeated measures ANOVA followed by Tukey’s muin screening for depression) or higher in the menstrual
and luteal phases.
The number of cigarettes smoked and CO concentra-
tion were correlated with the levels of craving for smoking
(VAS), depressiveness (CES-D) and menstrual phase-
associated symptoms (MDQ) in all phases except for
MDQ scores in the follicular phase (Table 3). The corre-
lation coefficients in the luteal phase were higher than
those in the other two phases. Compared with the number
of cigarettes smoked, the CO concentration showed a
higher correlation coefficiency to the CES-D and MDQ
scores in all phases, whereas it showed lower correlation
coefficiency to the levels of craving for smoking in the
menstrual and follicular phases.
Discussion
To accurately examine the relationships between the
amount of smoking versus levels of craving for smoking,
depression, and menstrual phase-associated symptoms
among the menstrual, follicular, and luteal phases, we
improved the methodological issues described in former
studies. The first problematic issue is the definition of
the menstrual phases. We clearly defined the menstrual
phases for each subject, as described in Materials and
Methods. Benowitz et al. reported that estrogens acceler-
ated the nicotine metabolism by comparison between
women versus men [18], but the activity of cytochrome
P450 2A6, which is primarily responsible for nicotine
metabolism, was not affected by menstrual cycle phase
[19]. Since the level of sex hormones fluctuated during
the menstrual cycle, the association of ovarian hormones
and smoking behavior has been examined in recent psy-
chological studies [20-22]. These studies attempted to
directly examine the pharmacological effect of progester-
one and/or estrogen (e.g., hormonal contraception) on
women’s sensitivity to nicotine, but such effects on
smoking behavior are also unclear. As oral contracep-
tives were reported to accelerate the nicotine metabo-
lism [18], women using hormonal contraceptives were
excluded. Secondly, there is an issue with the method
for measuring breath CO and urinary cotinine levels as
objective indices of the amount of smoking. In previous
studies [6,7,9,10], these biomarkers were measured once
in each menstrual cycle when the subjects visited a hospitald CO concentration) in the menstrual, follicular and
ar mean (SD) Luteal mean (SD) p-value partial η2
.7 (5.4)1) 18.3 (4.9)1) 0.007 0.081
.0–22.0 10.0–30.0










Figure 1 Craving for smoking, depressiveness and menstrual
phase-associated symptoms in the menstrual, follicular and
luteal phases. Scores of Craving (VAS) were 61.4 ± 16.7, 42.2 ± 18.6
and 65.0 ± 18.2 in the menstrual, follicular and luteal phases. Scores
of Depressiveness (CES-D) were 16.9 ± 8.2, 11.3 ± 6.9 and 17.2 ± 8.4 in
the menstrual, follicular and luteal phases. Scores of Menstrual
phase-associated symptoms (MDQ) were 44.5 ± 18.2, 18.9 ± 17.0 and
37.7 ± 15.9 in the menstrual, follicular and luteal phases.
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vary every day, measurement should be performed much
more frequently. In the present study, breath CO levels
were measured every day to reduce such bias. Additionally,
Craig et al. [2] mentioned that women smokers tended to
drink alcohol before a menstrual period, which could have
caused an increase in the amount of smoking in the luteal
phase. In this study, the data on days when the subjects
drank alcohol or had no chance to smoke were excluded
from the statistical analysis. We then concluded that the
number of cigarettes smoked by young Japanese women
and their breath CO levels significantly increased in the
luteal phase compared with the follicular phase.Table 3 Correlation coefficiency between thpfe amount of sm
menstrual phase-associated symptoms in the menstrual, folli
Craving (VAS) Number of cigarettes 0
CO concentration 0
Depressiveness (CES-D) Number of cigarettes 0
CO concentration 0
Menstrual phase-associated symptoms(MDQ) Number of cigarettes 0
CO concentration 0
* p < 0.05, ** p < 0.01,*** p < 0.001.
95% CI: 95% confidence interval.In this study, the level of craving for smoking in young
Japanese women smokers in the menstrual and luteal
phases was higher compared to the follicular phase with-
out smoking cessation. Just as a long period of smoking
cessation induces withdrawal symptomatology, a strong
craving for smoking is sometimes noted even in smokers.
Previous studies reported that the level of craving for
smoking was higher and the power of concentration was
decreased more in the menstrual phase compared with
the follicular phase [6], and that withdrawal symptoms
worsened in the luteal phase [6,7,23]. The present study
also identified a strong positive correlation between the
levels of craving for smoking and the amount of smoking
in the luteal phase.
The levels of depressiveness in young Japanese women
smokers in the menstrual and luteal phases were also
higher compared to the follicular phase. The subjects of
the study did not have premenstrual syndrome (inclu-
ding premenstrual dysphoric disorder) or dysmenorrhea.
Nevertheless, the mean CES-D scores in the menstrual
and luteal phases were 16 or higher - an indication of
depression. This suggests that the level of depressiveness
in young Japanese women smokers changes according to
the menstrual cycle, and that a large number of these
smokers develop depressiveness in the luteal phase.
When screening the level of depressiveness in women
smokers, careful attention should be paid to the rela-
tionship between the time of measurement and the
menstrual cycle. There was a stronger correlation between
the amount of smoking and the level of depressiveness
in the luteal phase compared with other phases. The
relationship between smoking and depression is well-
recognized [24,25] and further studies should be con-
ducted to determine whether depression in the luteal
phase causes an increase in the amount of smoking or
smoking increases the level of depression.
MDQ scores were high in both the menstrual (44.5 ±
18.2) and luteal (37.7 ± 15.9) phases. Our previous study
reported that young Japanese female smokers showed
levels that could be considered symptoms (MDQ score;oking and levels of craving for smoking, depression, and
cular and luteal phases
Menstrual Follicular Luteal
r 95% CI r 95% CI r 95% CI
.611*** 0.20–0.84 0.598*** 0.18–0.83 0.718*** 0.38–0.89
.530** 0.09–0.80 0.430* 0.08–0.69 0.811*** 0.55–0.93
.387* 0.02–0.66 0.374* 0.01–0.65 0.546** 0.24–0.77
.490** 0.03–0.78 0.484** 0.02–0.78 0.607*** 0.20–0.84
.405* 0.05–0.67 0.097 −0.28–0.45 0.530** 0.08–0.80
.488** 0.03–0.78 0.274 −0.10–0.58 0.588** 0.17–0.83
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phase) [12]. In the menstrual and luteal phases, a moderate
positive correlation was noted between MDQ scores and
the amount of smoking. However, there was no significant
correlation between them in the follicular phase. Although
the MDQ subscale includes “negative emotions” similar to
“depressiveness”, the correlations with the amount of smok-
ing differed from each other in the follicular phase. This
suggests that factors other than depressiveness may also
contribute to the correlation with the amount of smoking
in the menstrual and luteal periods.
Limitations
In this study, the subjects were 29 young Japanese
female smokers aged from 19 to 25 years old. Smoking
behavior and the menstrual phase-associated symptoms
vary among countries, cultures and ages. The correla-
tions between the amount of smoking and several symp-
toms shown in the study were possibly limited to these
study subjects. Generalization of our results should be
made only with caution. In addition, no cause-effect
relationship between the amount of smoking and these
symptoms has been determined. Further studies will be
needed in the future.
Conclusions
In the menstrual and luteal phases, young Japanese women
smokers increased their amount of smoking and suffered
from greater craving for smoking, depressiveness and
menstrual phase-associated symptoms compared with the
follicular phase. The amount of smoking was correlated
with these symptoms, but their cause-effect relationship
has not been determined yet.
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